Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-25-012679
Filing Date
2025-05-12
Accepted
2025-05-12 17:00:20
Documents
1
Period of Report
2025-05-08

Document Format Files

Seq Description Document Type Size
1 form4-05122025_050505.html 4  
1 form4-05122025_050505.xml 4 4319
  Complete submission text file 0001415889-25-012679.txt   5934
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Issuer) CIK: 0000890821 (see all company filings)

EIN.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 10 CLEVELAND ST A SOMERVILLE MA 02143-2606
Business Address
Coveney Kevin Michael (Reporting) CIK: 0001967056 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38286 | Film No.: 25935826